Deal of The Day! Hurry Up, Grab the Special Discount - Save 25% - Ends In 00:00:00 Coupon code: SAVE25
Welcome to Pass4Success

- Free Preparation Discussions

AMA Exam PCM Topic 1 Question 67 Discussion

Actual exam question for AMA's PCM exam
Question #: 67
Topic #: 1
[All PCM Questions]

Saleye Pharmaceuticals develops cheaper alternatives to proprietary drugs. Its mission statement states that it wants to create affordable medicine for everyone and create a healthier world. Saleye releases a new and improved version of its pain-relieving drug, Fento. Within a week, Saleye receives many complaints stating that the drug is inducing hallucinations and in some cases triggering certain anxiety disorders. Saleye was caught off-guard as its animal and human trials did not reveal any side effects. Saleye deliberated over the decision to recall the drug for over a week and by the time it eventually did, it had lost millions in stocks. Where did Saleye fail?

Show Suggested Answer Hide Answer
Suggested Answer: D

Contribute your Thoughts:

Quentin
2 months ago
I think the answer is B - Saleye didn't have the proper control measures in place to catch these serious side effects before releasing the drug. Their animal and human trials were clearly not comprehensive enough.
upvoted 0 times
Leota
29 days ago
C) It did not consider the target market before creating its drug.
upvoted 0 times
...
Scot
1 months ago
B) It did not have control measures in place.
upvoted 0 times
...
Fabiola
1 months ago
A) It did not have an ethical mission statement.
upvoted 0 times
...
...
Sena
3 months ago
Haha, 'a healthier world'? More like a world of hallucinating patients! Saleye needs to go back to the drawing board and remember that 'affordable' doesn't mean 'cutting corners'.
upvoted 0 times
Sharan
1 months ago
C) It did not consider the target market before creating its drug.
upvoted 0 times
...
Brandon
1 months ago
B) It did not conduct large-scale human trials.
upvoted 0 times
...
Leota
2 months ago
A) It did not have control measures in place.
upvoted 0 times
...
...
Marge
3 months ago
This is a classic case of prioritizing profits over safety. Saleye should have put the wellbeing of patients first, instead of rushing an untested drug to market. Their mission statement rings hollow now.
upvoted 0 times
Mitzie
2 months ago
This is a classic case of prioritizing profits over safety. Saleye should have put the wellbeing of patients first, instead of rushing an untested drug to market. Their mission statement rings hollow now.
upvoted 0 times
...
Tegan
2 months ago
B) It did not conduct large-scale human trials.
upvoted 0 times
...
Tasia
2 months ago
A) It did not have control measures in place.
upvoted 0 times
...
...
Brandon
3 months ago
Saleye clearly dropped the ball on quality control and testing. Skimping on large-scale human trials was a huge oversight, and their greed for profits blinded them to the real-world consequences.
upvoted 0 times
Ahmed
23 days ago
D) It did not consider the target market before creating its drug.
upvoted 0 times
...
Lura
24 days ago
C) It prioritized profits over effective drugs.
upvoted 0 times
...
Callie
25 days ago
B) It did not conduct large-scale human trials.
upvoted 0 times
...
Nguyet
29 days ago
A) It did not have control measures in place.
upvoted 0 times
...
Hayley
1 months ago
C) It prioritized profits over effective drugs.
upvoted 0 times
...
Andra
1 months ago
B) It did not conduct large-scale human trials.
upvoted 0 times
...
Adolph
2 months ago
A) It did not have control measures in place.
upvoted 0 times
...
...
Billye
3 months ago
I agree with Colene. They should have had better monitoring in place to catch these side effects earlier.
upvoted 0 times
...
Colene
3 months ago
Yeah, it's really concerning. I think they failed because they didn't have control measures in place.
upvoted 0 times
...
Mertie
4 months ago
I can't believe Saleye Pharmaceuticals messed up with their new drug.
upvoted 0 times
...

Save Cancel